Medicure Inc. (CVE:MPH – Get Free Report)’s stock price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$1.16 and traded as high as C$1.16. Medicure shares last traded at C$1.16, with a volume of 3,081 shares traded.
Medicure Stock Up 4.5%
The firm has a market capitalization of C$12.11 million, a price-to-earnings ratio of -1.78 and a beta of 0.62. The stock has a 50 day moving average of C$1.16 and a 200 day moving average of C$1.17. The company has a quick ratio of 1.29, a current ratio of 1.04 and a debt-to-equity ratio of 6.34.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.
See Also
- Five stocks we like better than Medicure
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
